2011 AASLD Poster/Abstract Submissions
A look at this year's submissions from the U of L Division of Gastroenterology, Hepatology & Nutrition at the annual "The Liver Meeting®" of the American Association for the Study of Liver Disease.
GG treatment potentiates intestinal hypoxia-inducible factor, promotes intestinal integrity, and ameliorates alcohol-induced liver injury.
Wang Y, Kirpich I, Liu Y, Ma Z, Barve S, McClain CJ, Feng W
Monocytic myeloid-derived suppressor cells mediated hepatic inflammation and blunt liver injury healing in mouse model of high fat diet.
Xie Q, Zhang J, Ghare S, Barve S, McClain CJ
Polychlorinated Biphenyl 153 Worsens Hepatic Steatosis In Mice Fed A High Fat Diet And Differentially Regulates 40 Liver Metabolites:Preliminary Results Of A Metabolomics Analysis.
Wahlang B, Zhang X, Falkner KC, McClain CJ, Cave MC.
Multiple cell-death mechanisms are triggered in hepatotoxicity induced by acrolein, an environmental pollutant and lipid peroxidation product.
Avila D, Mohammad MK, Zhang J, Arteel GE, McClain CJ, Barve S, Joshi-Barve S.
Targeting Hepatic Glycosaminoglycans (GAGs)-Cytokine Interactions Protects Mice from Concanavalin A-induced Immune Hepatitis (CIH).
Barve S, Gobejishvili L, Zhang J, Joshi-Barve S, Fernandez-Botran GR, McClain CJ.
A Comparison Of Serum Adipocytokines, Cytokeratin 18, And Antioxidants In Humans With Steatohepatitis Due To Alcohol (ASH), Obesity (NASH), And Industrial Chemicals (TASH).
Falkner KC, Mannery Y, Wahlang B, McClain CJ, Cave MC.